Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.08. | BIMobject AB: BIMobject: Interim Report April-June 2024 | 40 | GlobeNewswire (Europe) | Second quarter financial highlightsARR in constant currencies of MSEK 138.4 (128.1) at end of quarter, +8%Net sales of MSEK 41.8 (39.6), +6%, including a currency effect of +1%Net sales from recurring... ► Artikel lesen | |
02.08. | Helport AI Limited and Tristar Acquisition I Corp. Announce Closing on Reduced $5.5 Million PIPE Investment Concurrently with Closing of Business Combination | 118 | GlobeNewswire (Europe) | SINGAPORE and BURLINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Helport AI Limited (together with its operating subsidiaries, "Helport"), an AI technology company serving enterprises' customer... ► Artikel lesen | |
02.08. | CSE Bulletin: Reinstatement - Tantalex Lithium Resources Corporation (TTX) | 90 | Newsfile | le 2 août/August 2024
Effective immediately, Tantalex Lithium Resources Corporation will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec... ► Artikel lesen | |
02.08. | Ginkgo Bioworks to Hold Special Meeting of Shareholders | 114 | PR Newswire | Special meeting to take place virtually on August 14, 2024 at 4:00 pm ET
BOSTON, Aug. 2, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform... ► Artikel lesen | |
02.08. | OCI N.V.: OCI Global Reports Q2 2024 Results | 273 | GlobeNewswire (Europe) | Financial Highlights
• OCI Global (Euronext: OCI) reported total Q2 2024 revenues of $1,211 million, a 12% reduction YoY, and total Q2 2024 adjusted EBITDA of $296 million, a decrease of 9% YoY.... ► Artikel lesen | |
02.08. | Zevra Therapeutics: FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C | 316 | GlobeNewswire (Europe) | CELEBRATION, Fla., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that the U.S. Food and... ► Artikel lesen | |
02.08. | Digicann Ventures Inc.: Digicann Ventures and 3Win Corp. Sign Binding LOI for Proposed RTO Transaction | 413 | GlobeNewswire (Europe) | /Not for distribution to U.S. news wire services or for dissemination in the United States/ VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or the... ► Artikel lesen | |
02.08. | Bluewater Acquisition Corp. and AlphaDelta Management Corp. Announce Termination of LOI | 163 | GlobeNewswire (Europe) | CALGARY, Alberta, and VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bluewater Acquisition Corp. ("Bluewater") (TSXV: BAQ.P) and AlphaDelta Management Corp. ("ADM") jointly announce... ► Artikel lesen | |
02.08. | JOYY Inc.: JOYY Announces Leadership Transition | 150 | GlobeNewswire (Europe) | SINGAPORE, Aug. 03, 2024 (GLOBE NEWSWIRE) -- JOYY Inc. (Nasdaq: YY) ("JOYY" or the "Company"), a global technology company, today announced that its board of directors (the "Board") has approved a... ► Artikel lesen | |
02.08. | Chibougamau Independent Mines Inc.: Termination of TomaGold's Option for the Acquisition of Chibougamau's East Block | 209 | GlobeNewswire (Europe) | ROUYN-NORANDA, Québec, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart, Berlin and Lang & Schwarz Stock Exchanges in Germany, CMAUF-OTC... ► Artikel lesen | |
02.08. | Tourmaline Bio, Inc.: Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024 | 164 | GlobeNewswire (Europe) | Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and monthly subcutaneous administration... ► Artikel lesen | |
02.08. | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 129 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address... ► Artikel lesen | |
02.08. | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 162 | GlobeNewswire (Europe) | SAN FRANCISCO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development... ► Artikel lesen | |
02.08. | Mural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 145 | GlobeNewswire (Europe) | WALTHAM, Mass. and DUBLIN, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies... ► Artikel lesen | |
02.08. | TWC Enterprises Limited Announces Second Quarter 2024 Results and Eligible Dividend | 126 | GlobeNewswire (Europe) | KING CITY, Ontario, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Consolidated Financial Highlights (unaudited) (in thousands of dollars except per share amounts)Three months endedSix months endedJune... ► Artikel lesen | |
02.08. | NEXGOLD MINING CORP: NexGold Mining Announces New OTCQX Ticker Symbol | 265 | GlobeNewswire (Europe) | TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG) (OTCQX: NXGCF) (the "Company" or "NexGold") is pleased to announce that it will begin trading at market open on August... ► Artikel lesen | |
02.08. | Helport AI Limited and Tristar Acquisition I Corp. Announce Closing of Business Combination and listing on Nasdaq | 215 | GlobeNewswire (Europe) | SINGAPORE and BURLINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Helport AI Limited (together with its operating subsidiaries, "Helport") (Nasdaq: HPAI), an AI technology company serving enterprise... ► Artikel lesen | |
02.08. | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 205 | GlobeNewswire (Europe) | BOSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on July 31, 2024... ► Artikel lesen | |
02.08. | JIADE LIMITED Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency | 279 | GlobeNewswire (Europe) | Chengdu, China, Aug. 02, 2024 (GLOBE NEWSWIRE) -- JIADE LIMITED (Nasdaq: JDZG) (the "Company"), a company that specializes in providing one-stop comprehensive education supporting services to adult... ► Artikel lesen | |
02.08. | electroCore, Inc.: electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) | 186 | GlobeNewswire (Europe) | ROCKAWAY, N.J., Aug. 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on August... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 7.432 |
BAYER | 6.230 |
EVOTEC | 6.219 |
NVIDIA | 5.278 |
TUI | 3.573 |
RENK GROUP | 3.190 |
TESLA | 2.983 |
RHEINMETALL | 2.817 |
NEL | 2.771 |
MICROSTRATEGY | 2.631 |
VOLKSWAGEN | 1.289 |
BYD | 1.198 |
DEUTSCHE BANK | 1.111 |
PLUG POWER | 1.052 |
BASF | 1.008 |
COMMERZBANK | 994 |
PALANTIR TECHNOLOGIES | 941 |
AMAZON | 907 |
JINKOSOLAR | 903 |
MERCEDES-BENZ | 887 |
DEUTSCHE TELEKOM | 881 |
ALLIANZ | 878 |
INTEL | 866 |
THYSSENKRUPP | 836 |
HUGO BOSS | 832 |